Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3139870 | 0.83 | MEN1 (0.48) | TK1MEN1TSHRKMT2A | |
| SCHEMBL24540183 | 0.79 | MEN1 (0.50) | TK1MEN1TSHRKMT2A | |
| SCHEMBL3820444 | 0.79 | STAT3 (0.38) | — | |
| SCHEMBL3457921 | 0.78 | MEN1 (0.50) | TK1MEN1TSHRKMT2A | |
| SCHEMBL3133440 | 0.77 | TDP1 (0.43) | KMT2A | |
| SCHEMBL30089845 | 0.77 | TDP1 (0.43) | KMT2A | |
| SCHEMBL4843329 | 0.76 | TK1 (0.32) | TK1MEN1TSHRKMT2A | |
| SCHEMBL3134619 | 0.76 | MEN1 (0.52) | TK1MEN1TSHRKMT2A | |
| SCHEMBL21525080 | 0.76 | TK1 (0.33) | TK1MEN1TSHRKMT2A | |
| SCHEMBL28478877 | 0.76 | SLC2A1 (0.36) | MEN1TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114685606-A | Synthetic method of peptide nucleic acid guanine monomer | 苏州怡彼得生物技术有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-114685606-A | Synthetic method of peptide nucleic acid guanine monomer | 苏州怡彼得生物技术有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114685606-A | Synthetic method of peptide nucleic acid guanine monomer | 苏州怡彼得生物技术有限公司 | 2022-07-01 | — | — | CN | disclosed |
| EP-2174936-B1 | PNA monomer and precursor | PANAGENE INC (KR) | 2013-09-04 | — | — | EP | disclosed |
| EP-2174936-A1 | PNA monomer and precursor | Panagene, Inc. (KR) | 2010-04-14 | — | — | EP | disclosed |
| EP-1501812-B1 | PNA MONOMER AND PRECURSOR | PANAGENE INC (KR) | 2009-12-30 | — | — | EP | disclosed |
| EP-1651642-B1 | PNA MONOMER AND PRECURSOR | PANAGENE INC (KR) | 2009-11-04 | — | — | EP | disclosed |
| US-7411065-B2 | Peptide nucleic acid monomers: diphenylmethyl, benzyl, alkylthioalkyl, or phenylthioalkyl esters of N-(1-[4-(2-benzothiazolyl-, 2-benzoxazolyl-, 2-benzofuranyl- or 2-benzothiophenyl-sulfonyl)-3-piperazinon-1-ylcarbonylmethyl]pyrimidon-4-yl)carbamic acids | PANAGENE, INC. (KR) | 2008-08-12 | — | — | US | disclosed |
| US-7371860-B2 | PNA monomer and precursor | PANAGENE, INC. (KR) | 2008-05-13 | — | — | US | disclosed |
| US-7371859-B2 | Peptide nucleic acid monomers; 1-(4-(benzothiazolyl-, benzoxazolyl-, benzofuranyl-, and benzothiophenyl- sulfonyl)piperidin-3-one-1-ylcarbonylmethyl)adenines; suitable for automatic and parallel synthesis; increased yields | PANAGENE, INC. (KR) | 2008-05-13 | — | — | US | disclosed |
| US-20050283005-A1 | PNA monomer and precursor | KIM SUNG K | 2005-12-22 | — | — | US | disclosed |
| US-6969766-B2 | PNA monomer and precursor | PANAGENE, INC. (KR) | 2005-11-29 | — | — | US | disclosed |
| US-20050250785-A1 | PNA monomer and precursor | PANAGENE, INC. (KR) | 2005-11-10 | — | — | US | disclosed |
| US-20050250786-A1 | PNA monomer and precursor | PANAGENE, INC. (KR) | 2005-11-10 | — | — | US | disclosed |
| US-20050026930-A1 | PNA monomer and precursor | PANAGENE, INC. (KR) | 2005-02-03 | — | — | US | disclosed |
| WO-2005009998-A1 | PNA MONOMER AND PRECURSOR | PANAGENE INC. (US) | 2005-02-03 | — | — | WO | disclosed |
| EP-1501812-A1 | PNA MONOMER AND PRECURSOR | Panagene, Inc. (KR) | 2005-02-02 | — | — | EP | disclosed |
| US-20030225252-A1 | PNA monomer and precursor | PANAGENE, INC. (KR) | 2003-12-04 | — | — | US | disclosed |
| WO-2003091231-A1 | PNA MONOMER AND PRECURSOR | PANAGENE, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| US-20030195332-A1 | PNA monomer and precursor | PANAGENE, INC. (KR) | 2003-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195332-A1 | PNA monomer and precursor | RNGTT, NGLY1, NCL | TK1 454/4885MEN1 961/4885TSHR 954/4885 |
| US-20050283005-A1 | PNA monomer and precursor | PNISR, RNGTT, POLL | TK1 211/4885MEN1 3369/4885TSHR 488/4885 |
| US-20050250785-A1 | PNA monomer and precursor | PNISR, RNGTT, POLL | TK1 211/4885MEN1 3369/4885TSHR 488/4885 |
| US-20030225252-A1 | PNA monomer and precursor | PNISR, RNGTT, NCL | TK1 242/4885MEN1 3281/4885TSHR 372/4885 |
| US-20050026930-A1 | PNA monomer and precursor | RNGTT, POLL, NSUN3 | TK1 584/4885MEN1 1967/4885TSHR 379/4885 |
| US-20050250786-A1 | PNA monomer and precursor | PNISR, RNGTT, NPR1 | TK1 171/4885MEN1 3505/4885TSHR 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.